Gujarat Themis Biosyn Ltd

Guj. Themis Bio. | 506879

Market Closed

₹378.95

+₹4.38 (+1.17%)

As on 11/07/26, 12:30 AM

Market Cap4,129.24 CR

Current Price₹378.95

High / Low₹479 / 225.05

PE Ratio---

Book Value₹---

Dividend Yield---

ROCE---

ROE21.69%

Face Value₹2.00

Current Vol.1,78,110

Average Vol.---

ISININE942C01045

PB Ratio---

Debt to Equity---

Net Profit Margin---

Operating Margin---

Share Price Chart - Gujarat Themis Biosyn Ltd

+₹0.00 (+0.00%)6M

Stock Performance

₹374.55₹377.2

₹378.95

Previous CloseToday's Open

₹225.05₹479

₹378.95

52W Low52W High

₹377.2Today's Open

₹374.55Previous Close

1,78,110Volume

₹225.0552W Low

₹47952W High

Ratios

📊

Consolidated data not available

Please try selecting a different data type

About Company

Promoted byJayshree D Patel, Gujarat Themis Biosyn Limited (GTBL) was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd
The Company commenced production in August 1985
It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd
(PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd
, Cadila Health Care Ltd
(Zydus) and Lyka Labs Ltd
It is actively managed by Themis Medicare Ltd
(JV company of Gedeon Richter Ltd, Hungary) since 2007
Initially manufacturing the antibiotic, erythromycin, GTBL obtained licences to manufacture bulk drugs like rifampicin, cephalexin, griseofulvin and their formulations in 1990
However, problems relating to purity levels, yield and imports put the company in the red and it became a BIFR case in 1990

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI45.19

SMA 20386.51

SMA 50384.51

SMA 100341.53

SMA 200372.53

SMA 10385.61

MACD_12_26_Days-1.00

EMA10Day382.52

EMA20Day385.31

EMA50Day375.79

MACD_12_26_9_Days-3.47

EMA100Day364.55

EMA200Day346.77

Pivot Points

Volume Analysis

Delivery

Total Volume

Growth Rate

📊

No Information Available

Growth Rate information is not available at this time.

All figures in ₹ Crores

📊

No Information Available

No profit & lossdata available

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

📊

No Data Available

No Block Deals data available for this company.

News

📊

No Information Available

No news available for this company.

Record Date

Corporate Action

Information

Announcement Day

12 Sept 2025

AGM

20 Aug 2025

05 Sept 2025

Final Dividend (₹0.67)

Recommended final dividend of Re. 0.67 i.e. @ 67% per equity share having face value of Re.1/- each aggregating to Re.7,30,06,728 for the Financial Year ended 31st March, 2025. The payment is subject to the approval of shareholders at the ensuing Annual General Meeting. The Record Date for the purpose of determining entitlement to receive the dividend for the financial year ended 315! March, 2025 has been fixed as 5' September, 2025. (As Per BSE Announcement Dated on :01.08.2025)

20 May 2025

09 Aug 2024

Bonus Issue (1:2)

1:2 Bonus Issue of Equity Shares

31 Jul 2024

23 Jul 2024

AGM

14 May 2024

16 Jul 2024

Final Dividend (₹0.25)

Please find our intimation on the captioned subject. Recommended divid e nd for Financial Year ended 31 st March, 2024 Rs. 0.25/ · i.e.@ 25% per- equity share having fa ce v alue of Re.1 /· aggregating to Rs. 1,81 ,60,877.50/ ·. The payment is subject to the appro·val of shareholders at the ensuing Annual Gene ral Meeting.

14 May 2024

22 Feb 2024

Interim Dividend (₹0.75)

Please refer the attached intimation Declaration of an Interim Dividend for the Financial Year 2023-24 of ? 0.75/- (Rupee SeventyFive paise only) per equity share having face value of ? 1/- i.e. 75.00% aggregating to? 5,44,82,632.50/- (Rupees Five Crore Forty-Four Lakhs Eighty-Two Thousand Six Hundred andThirty-Two and Fifty Paise only

10 Feb 2024

10 Oct 2023

Stock Split (1:5)

Face Value Change from 5 To 1

13 May 2023

09 Sept 2023

AGM

13 May 2023

02 Sept 2023

Final Dividend (₹1)

The Board of Directors at its meeting held today, considered and approved the following matters: Recommended dividend for Financial Year ended 31.03.2023 of Rs.1/- i.e. @ 20% per equity share having face value of Rs.5/- , aggregating to Rs. 1,45,28,702. The payment is subject to the approval of shareholders at the ensuing AGM

13 May 2023

02 Dec 2022

Interim Dividend (₹4.4)

Meeting Commencement Time : 10:00 A.M Meeting Conclusion Time : 10:51 A.M The Board of Directors at its meeting held today, considered and approved the following: Declaration of an Interim Dividend for the Financial Year 2022-23 of 4.40/- (Rupees Four and forty paise only) per equity share having face value of 5/- i.e. 88% aggregating to 6,39,26,289/- (Rupees Six Crore Thirty Nine lakhs twenty six thousand two hundred eighty nine only)

21 Nov 2022

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
379			0
1,935	4,64,331	37	6	30	0	19.78%
6,836	1,81,466	69	11	59	0	23.41%
4,903	1,65,952	76	20	50	1	11.09%
1,439	1,16,229	31	3	23	0	9.92%
1,151	1,14,763	21	4	17	0	19.86%
2,496	1,14,128	20	5	16	0	14.56%
2,525	1,04,275	52	6	36	0	14.39%
1,246	1,03,959	26	3	17	0	12.34%
1,565	90,875	26	2	17	0	10.98%

Showing 10 of 135 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

DIXONDixon Technologies (India) Ltd
₹13,421-56 (-0.42%)

Frequently Asked Questions

What is Share Price of Gujarat Themis Biosyn Ltd?

The current share price of Gujarat Themis Biosyn Ltd (Guj. Themis Bio.) is ₹378.95. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the 52-week high and low of Gujarat Themis Biosyn Ltd?

Gujarat Themis Biosyn Ltd has a 52-week high of ₹479.00 and a 52-week low of ₹225.05. This range shows the stock's price volatility over the past year.

What is the ROE of Gujarat Themis Biosyn Ltd?

Gujarat Themis Biosyn Ltd has a Return on Equity (ROE) of 21.69%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds. Play Video